GSK Stockmann has advised a major Swiss asset manager in Germany on the purchase of a 17,600 sqm portfolio of care facilities in southern North Rhine-Westphalia.

The asset manager is acquiring the portfolio for an institutional healthcare real estate fund. The portfolio comprises three fully inpatient care facilities with a total of 270 care places and 55 assisted living flats in Würselen, Eschweiler and Meckenheim. The properties each offer more than 5,000 square metres of usable space and have an occupancy rate of over 95%.

The portfolio comprises the following three facilities:

• “Senioren-Park Carpe Diem” in Würselen: Covering a total area of around 5,640 square metres, the facility has more than 90 fully inpatient single room beds and six assisted living units.
• “AGO Seniorenzentrum Eschweiler”: The facility comprises a total area of around 6,500 square metres with a single room ratio of 94%.
• “Johanniter-Stift Meckenheim”: The facility offers 80 single rooms for fully inpatient care and 24 assisted living places over an area of 5,480 square metres.

A GSK Stockmann team led by Berlin-based partner Philip Huperz provided comprehensive legal advice on the acquisition of the portfolio.

Advisers:

GSK Stockmann: Philip Huperz (lead), Julia Jacobs (both real estate transactions and investments), Kristina Marx, Leonie Becker, Christine Toman (public law), Dominik Berka, Marc Nostitz (tax law)

Other advisers:

IMMOTISS care GmbH, Cushman & Wakefield